Form 4: Aurinia CFO Miller Reports Routine RSU Tax Withholding

Aurinia Pharmaceuticals' CFO, Joseph M. Miller, reported a routine disposition of 32,424 common shares to cover tax obligations from restricted stock unit vesting.

Summary

• Joseph M. Miller, Chief Financial Officer of Aurinia Pharmaceuticals Inc. (AUPH), reported a transaction on February 20, 2026.
• The transaction involved the disposition of 32,424 shares of Common Stock.
• These shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
• The shares were disposed of at a price of $14.4 per share.
• Following this transaction, Mr. Miller beneficially owns 556,703 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a standard, non-discretionary transaction related to executive compensation and tax obligations, carrying no inherent positive or negative implications for the company's operational performance or future prospects.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine tax withholding transactions, such as this one, are common occurrences for executives receiving equity compensation like Restricted Stock Units (RSUs). They typically do not reflect a discretionary sale based on market sentiment but rather a pre-determined mechanism to cover tax liabilities upon vesting.

Comparison to Industry Standards

• This type of transaction (Code 'F' for tax withholding) is a standard practice across industries for executives whose compensation includes equity awards, aligning with typical RSU vesting and tax payment protocols.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction related to executive compensation, not a discretionary sale.

Key Dates

Keywords

Aurinia Pharmaceuticals, AUPH, Joseph M. Miller, CFO, Form 4, SEC filing, restricted stock units, RSU vesting, tax withholding, insider transaction